A correlation between intra-hepatic IL-34 and load of HBV from HBV induced HCC patients has also been observed, suggesting local and systemic IL-34 participates in the host immunity against HBV infection and subsequent inflammation, and eventually toward malignancy following long-term persistent liver damage (5). Here, IL34 is linked to hepatocellular carcinoma.